Bradley van Paridon

Researchers sought to determine whether individuals recovered from mildly symptomatic COVID-19 develop and sustain immunological memory against the SARS-CoV-2 virus.

Neutrophil-to-lymphocyte ratio may be a valuable biomarker to help clinicians recognize severe COVID-19 infection with moderate to severe ARDS.

Despite treatment with antiretroviral therapies, people with HIV may be more likely to experience severe manifestations of COVID-19.

The intensive care unit (ICU) community needs to prepare for the challenges associated with the coronavirus disease 2019 (COVID-19) pandemic.

A new pooling method for SARS-CoV-2 diagnostic testing that uses standard protocols, reagents and equipment can be applied immediately in current clinical testing laboratories.

Epidemiologic, clinical, microbiologic and antimicrobial resistance (AMR) data on nosocomial superinfections during the coronavirus disease 2019 (COVID-19) pandemic is needed to inform stewardship.

As of April 2020, more than 9200 cases of coronavirus disease 2019 (COVID-19) were reported among US healthcare personnel.

Among 121 healthcare personnel exposed to a patient with unrecognized COVID-19, 43 became symptomatic and 3 tested positive for SARS-CoV-2.

Seven epidemiologic clusters of coronavirus disease 2019 (COVID-19) that were likely caused by presymptomatic transmission have been identified in Singapore.